Survival of advanced melanoma patients with normal LDH treated with oblimersen, temozolomide, and nab-paclitaxel
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. C. Pavlick, P. Ott, J. Escalon, K. Madden, E. Yepes, J. Staha, S. Mendoza, A. Gandhi, H. Yee, L. Liebes
Institution: New York University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2268502020
